Standard Chemical & Pharmaceutical Co. Ltd. (TPE:1720)
60.50
0.00 (0.00%)
Apr 2, 2025, 1:30 PM CST
TPE:1720 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 880.5 | 834.89 | 815.41 | 706.73 | 524.17 | Upgrade
|
Depreciation & Amortization | 402.08 | 344.97 | 295.21 | 217.41 | 228.98 | Upgrade
|
Other Amortization | 2.66 | 2.81 | 3.4 | 3.66 | 4.8 | Upgrade
|
Loss (Gain) From Sale of Assets | 5.47 | -1.27 | 7.78 | -73.78 | 0.08 | Upgrade
|
Asset Writedown & Restructuring Costs | - | - | - | 1.81 | - | Upgrade
|
Loss (Gain) From Sale of Investments | 0.67 | -2.89 | -1.08 | -1.45 | 0.54 | Upgrade
|
Loss (Gain) on Equity Investments | 11.36 | -41.56 | -61.37 | 6.16 | -3.05 | Upgrade
|
Provision & Write-off of Bad Debts | 11.52 | -9.07 | 17.81 | 0.93 | -6.44 | Upgrade
|
Other Operating Activities | 399.09 | 365.66 | 421.37 | 246.52 | 170.71 | Upgrade
|
Change in Accounts Receivable | -74.28 | 18.83 | -123.1 | -42 | -82.22 | Upgrade
|
Change in Inventory | -105.61 | -261.59 | -187.63 | -41.14 | 3.24 | Upgrade
|
Change in Accounts Payable | -26.84 | 40.64 | -93.89 | 105.31 | 45.77 | Upgrade
|
Change in Unearned Revenue | 11.78 | -0.79 | 4.88 | -56.58 | 41.64 | Upgrade
|
Change in Other Net Operating Assets | 150.11 | 46.18 | 170.06 | -248.54 | -5.11 | Upgrade
|
Operating Cash Flow | 1,695 | 1,337 | 1,228 | 827.03 | 922.58 | Upgrade
|
Operating Cash Flow Growth | 26.82% | 8.85% | 48.46% | -10.36% | 41.40% | Upgrade
|
Capital Expenditures | -596.48 | -625.7 | -1,196 | -213.48 | -352.52 | Upgrade
|
Sale of Property, Plant & Equipment | 15.59 | 1.53 | 0.72 | 245.64 | 0.21 | Upgrade
|
Cash Acquisitions | - | - | -24.32 | 1,028 | - | Upgrade
|
Sale (Purchase) of Intangibles | -5.47 | -2.72 | -4.01 | -4.81 | -0.16 | Upgrade
|
Investment in Securities | -192.35 | 159.99 | 98.66 | -209.47 | -313.07 | Upgrade
|
Other Investing Activities | 7.02 | -18.6 | 44.17 | -27.23 | -44.63 | Upgrade
|
Investing Cash Flow | -771.69 | -485.51 | -1,081 | 819.12 | -710.17 | Upgrade
|
Short-Term Debt Issued | 1,093 | 1,978 | 2,807 | 390.21 | 451 | Upgrade
|
Long-Term Debt Issued | - | 106.49 | 132 | 50 | - | Upgrade
|
Total Debt Issued | 1,093 | 2,084 | 2,939 | 440.21 | 451 | Upgrade
|
Short-Term Debt Repaid | -1,783 | -2,528 | -2,815 | -165.99 | -750 | Upgrade
|
Long-Term Debt Repaid | -83.86 | -29.97 | -22.45 | -18.48 | -16.35 | Upgrade
|
Total Debt Repaid | -1,866 | -2,558 | -2,837 | -184.47 | -766.35 | Upgrade
|
Net Debt Issued (Repaid) | -773.86 | -473.48 | 101.57 | 255.74 | -315.35 | Upgrade
|
Common Dividends Paid | -482.48 | -446.74 | -446.74 | -321.65 | -268.04 | Upgrade
|
Other Financing Activities | -187.97 | -155.91 | -120.27 | -51.63 | -60.58 | Upgrade
|
Financing Cash Flow | -1,444 | -1,076 | -465.44 | -117.54 | -643.98 | Upgrade
|
Foreign Exchange Rate Adjustments | 4.44 | 2.47 | 13.43 | -0.4 | -4.16 | Upgrade
|
Net Cash Flow | -516.62 | -222.64 | -305.01 | 1,528 | -435.72 | Upgrade
|
Free Cash Flow | 1,098 | 710.83 | 31.78 | 613.56 | 570.06 | Upgrade
|
Free Cash Flow Growth | 54.53% | 2136.85% | -94.82% | 7.63% | 20.09% | Upgrade
|
Free Cash Flow Margin | 16.18% | 11.39% | 0.54% | 13.33% | 13.24% | Upgrade
|
Free Cash Flow Per Share | 6.14 | 3.97 | 0.18 | 3.43 | 3.19 | Upgrade
|
Cash Interest Paid | 15.54 | 25.52 | 18 | 7.24 | 6.01 | Upgrade
|
Cash Income Tax Paid | 370.94 | 281.11 | 199.52 | 136.48 | 85.03 | Upgrade
|
Levered Free Cash Flow | 598.97 | 437.13 | -125.88 | -89.85 | 251.92 | Upgrade
|
Unlevered Free Cash Flow | 608.39 | 453.01 | -114.14 | -85.32 | 256.66 | Upgrade
|
Change in Net Working Capital | 67.22 | 53.55 | -88.37 | 636.12 | 66.09 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.